Home › Compare › DECXF vs JNJ

DECXF vs JNJ: Dividend Comparison 2026

DECXF yields 3703.70% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DECXF wins by $3419432698355.12M in total portfolio value
10 years
DECXF
DECXF
● Live price
3703.70%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3419432698355.14M
Annual income
$3,246,975,791,785,894,400.00
Full DECXF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DECXF vs JNJ

📍 DECXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDECXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DECXF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DECXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DECXF
Annual income on $10K today (after 15% tax)
$314,814.81/yr
After 10yr DRIP, annual income (after tax)
$2,759,929,423,018,010,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DECXF beats the other by $2,759,929,423,018,009,600.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DECXF + JNJ for your $10,000?

DECXF: 50%JNJ: 50%
100% JNJ50/50100% DECXF
Portfolio after 10yr
$1709716349177.58M
Annual income
$1,623,487,895,892,947,700.00/yr
Blended yield
94.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DECXF
No analyst data
Altman Z
10.5
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DECXF buys
0
JNJ buys
0
No recent congressional trades found for DECXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDECXFJNJ
Forward yield3703.70% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$3419432698355.14M ✓$20.0K
Annual income after 10y$3,246,975,791,785,894,400.00 ✓$827.78
Total dividends collected$3407630335185.05M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DECXF vs JNJ ($10,000, DRIP)

YearDECXF PortfolioDECXF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$381,070$370,370.37$10,676$355.77+$370.4K → DECXF
2$13,598,135$13,190,390.11$11,407$389.39+$13.59M → DECXF
3$454,444,009$439,894,003.67$12,198$426.53+$454.43M → DECXF
4$14,225,576,546$13,739,321,457.33$13,056$467.62+$14225.56M → DECXF
5$417,170,412,680$401,949,045,774.95$13,987$513.12+$417170.40M → DECXF
6$11,462,547,850,090$11,016,175,508,522.75$14,998$563.56+$11462547.84M → DECXF
7$295,153,060,460,047$282,888,134,260,450.30$16,098$619.52+$295153060.44M → DECXF
8$7,123,461,634,615,992$6,807,647,859,923,741.00$17,295$681.69+$7123461634.60M → DECXF
9$161,174,679,036,678,200$153,552,575,087,639,100.00$18,599$750.82+$161174679036.66M → DECXF
10$3,419,432,698,355,140,000$3,246,975,791,785,894,400.00$20,022$827.78+$3419432698355.12M → DECXF

DECXF vs JNJ: Complete Analysis 2026

DECXF — Stock

Decade Resources Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company holds a 65% interest in the Red Cliff property in north of Stewart, British Columbia; a 100% interest in the Goat property that consists of 8 claims totaling 1210.40 hectares located in British Columbia; and an option to earn a 100% interest in the Terrace property covering 48 contiguous mineral claims situated in British Columbia. It also holds an option agreement to acquire up to 75% interest in the Del Norte property comprising 5,830.16 hectares in 13 separate claims located in east British Columbia; and a 100% interest in the Grassy property that contains approximately 830.20 hectares in 2 separate claims situated in north of Stewart, British Columbia. In addition, the company holds interests in the Premier East property, which includes approximately 600 hectares in 7 separate claims located in British Columbia; and an option agreement to acquire up to 75% interest in the Lord Nelson property comprising of 2630 hectares in 6 separate claims situated in British Columbia. The company was incorporated in 2006 and is headquartered in Stewart, Canada.

Full DECXF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DECXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DECXF vs SCHDDECXF vs JEPIDECXF vs ODECXF vs KODECXF vs MAINDECXF vs ABBVDECXF vs MRKDECXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.